Indefinite Delivery Contract 75D30123D16651
Award Date 6/15/23
Last Date to Order 6/6/24
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $1,517,947,500.00 and a period of performance from April 1, 2022 through March 31, 2023. It is a multiple award contract vehicle that will provide up to 23 standard pediatric vaccines to support CDC's Immunization Awardees and the Vaccines for...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to procure a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The contract has a ceiling value of $1,914,795,500.00 and a period of performance from April 1, 2024 through March 31, 2025. The solicitation sought offers for 27 different pediatric vaccines including vaccines for diseases such as dengue, diphtheria,...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to provide a range of standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The $1.6 billion multiple-award IDC has a period of performance from April 1, 2021 through March 31, 2022, with no small business set-asides utilized. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024. The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. to supply a variety of standard pediatric vaccines over a 12-month period. The contract, valued at up to $1,530,970,000, will support the CDC's Vaccines for Children program, which provides immunizations to eligible children. The contract covers 20 different pediatric vaccines, including DTaP, Hepatitis A and B, Hib, HPV, MMR, Pneumococcal, Rotavirus, and Varicella, with minimum...
- The Centers for Disease Control and Prevention (CDC) has awarded a multiple award indefinite delivery indefinite quantity (IDIQ) contract for the purchase of standard commercial COVID-19 vaccines with a pediatric indication. The maximum ordering quantity is 30 million doses, with a minimum order of 100 doses. The vaccines procured will support pediatric immunization programs through the Vaccines for Children (VFC) and Section 317 vaccine purchase programs. The IDIQ has a ceiling value of...
- Pfizer Inc. has been awarded a multiple-award Indefinite Delivery contract valued at $2.21 billion by the Centers for Disease Control and Prevention (CDC) to supply pediatric vaccines for the Vaccines for Children (VFC) program. The contract period spans 12 months from April 1, 2025, through March 31, 2026, with no set-asides applied. Pfizer will deliver standard commercial pediatric vaccines to support immunization efforts for eligible populations, including Medicaid-eligible children,...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, to provide a wide range of pediatric vaccines over a period of performance from April 1, 2024 to March 31, 2025. The contract has a ceiling value of $1,334,738,300 and is part of the CDC's National Center for Immunization and Respiratory Diseases (NCIRD) effort to support pediatric immunization programs under...
- This is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production. The contract, with a ceiling value of $1,537,821,800, is for the procurement of 20 standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The period of performance is...
- The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...